NCT01430416View on ClinicalTrials.gov

Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

December 20, 2011

Primary Completion Date

May 22, 2019

Study Completion Date

May 22, 2019

Conditions
Uveal Melanoma
Interventions
DRUG

AEB071

Trial Locations (5)

10017

Memorial Sloan Kettering MSKCC 4, New York

75231

Novartis Investigative Site, Paris

02215

Dana Farber Cancer Institute DFCI - Brookline, Boston

2300 RC

Novartis Investigative Site, Leiden

SW3 6JJ

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY